FI903144A0 - MODIFIED VP1 / P2A ZONER I SNUVVIRUSSYSTEMET. - Google Patents
MODIFIED VP1 / P2A ZONER I SNUVVIRUSSYSTEMET.Info
- Publication number
- FI903144A0 FI903144A0 FI903144A FI903144A FI903144A0 FI 903144 A0 FI903144 A0 FI 903144A0 FI 903144 A FI903144 A FI 903144A FI 903144 A FI903144 A FI 903144A FI 903144 A0 FI903144 A0 FI 903144A0
- Authority
- FI
- Finland
- Prior art keywords
- snuvvirussystemet
- zoner
- modified
- protease
- trans
- Prior art date
Links
- 102000015636 Oligopeptides Human genes 0.000 abstract 2
- 108010038807 Oligopeptides Proteins 0.000 abstract 2
- 108091005804 Peptidases Proteins 0.000 abstract 2
- 239000004365 Protease Substances 0.000 abstract 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 2
- 230000035772 mutation Effects 0.000 abstract 2
- 108091026890 Coding region Proteins 0.000 abstract 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1009—Picornaviridae, e.g. hepatitis A virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
- C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32711—Rhinovirus
- C12N2770/32722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention relates to systems which make it possible to introduce mutations in the VP1/2A and in the complete coding region of the 2A protease, to test systems with which the "cis" and "trans" activity can be investigated, to oligonucleotides which encode the mutations, and to the oligopeptides derived therefrom and to the use thereof, furthermore oligopeptides which are cleaved by the 2A protease into trans with different efficiency, and to the use thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI951852A FI951852A (en) | 1989-06-25 | 1995-04-19 | Process for making test systems |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3920860 | 1989-06-25 | ||
DE4018376 | 1990-06-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
FI903144A0 true FI903144A0 (en) | 1990-06-21 |
Family
ID=25882343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI903144A FI903144A0 (en) | 1989-06-25 | 1990-06-21 | MODIFIED VP1 / P2A ZONER I SNUVVIRUSSYSTEMET. |
Country Status (17)
Country | Link |
---|---|
EP (2) | EP0410147B1 (en) |
JP (1) | JPH04503608A (en) |
KR (1) | KR920701439A (en) |
AT (1) | ATE114717T1 (en) |
AU (2) | AU644078B2 (en) |
CA (1) | CA2019661A1 (en) |
DE (2) | DE59007818D1 (en) |
DK (1) | DK0410147T3 (en) |
ES (1) | ES2064537T3 (en) |
FI (1) | FI903144A0 (en) |
GR (1) | GR3015192T3 (en) |
IE (2) | IE950434L (en) |
IL (2) | IL94841A0 (en) |
NO (1) | NO902789L (en) |
NZ (1) | NZ234212A (en) |
PT (1) | PT94458B (en) |
WO (1) | WO1991000348A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4136443A1 (en) * | 1991-11-06 | 1993-05-13 | Boehringer Ingelheim Int | EXPRESSION OF THE TIRE PROTEINASE 2A, ITS PARTIAL CLEANING AND PROVISION OF COMPETITIVE SUBSTRATES |
US8318423B2 (en) | 2004-07-06 | 2012-11-27 | Focus Diagnostics, Inc. | Methods and compositions for detecting rhinoviruses |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0263903A1 (en) * | 1986-10-10 | 1988-04-20 | E.I. Du Pont De Nemours And Company | Method for preparing specific inhibitors of virus-specified proteases |
ES2059482T3 (en) * | 1987-12-23 | 1994-11-16 | Boehringer Ingelheim Int | EXPRESSION OF HRV2 PROTEASE P2A CODED BY VIRUSES. |
-
1990
- 1990-06-21 FI FI903144A patent/FI903144A0/en not_active IP Right Cessation
- 1990-06-22 PT PT94458A patent/PT94458B/en not_active IP Right Cessation
- 1990-06-22 CA CA002019661A patent/CA2019661A1/en not_active Abandoned
- 1990-06-22 IE IE950434A patent/IE950434L/en unknown
- 1990-06-22 IL IL94841A patent/IL94841A0/en unknown
- 1990-06-22 NO NO90902789A patent/NO902789L/en unknown
- 1990-06-22 IE IE227090A patent/IE66395B1/en not_active IP Right Cessation
- 1990-06-25 ES ES90112064T patent/ES2064537T3/en not_active Expired - Lifetime
- 1990-06-25 WO PCT/EP1990/001015 patent/WO1991000348A1/en unknown
- 1990-06-25 EP EP90112064A patent/EP0410147B1/en not_active Expired - Lifetime
- 1990-06-25 NZ NZ234212A patent/NZ234212A/en unknown
- 1990-06-25 AU AU57796/90A patent/AU644078B2/en not_active Ceased
- 1990-06-25 DE DE59007818T patent/DE59007818D1/en not_active Expired - Fee Related
- 1990-06-25 EP EP93120518A patent/EP0602687A1/en not_active Withdrawn
- 1990-06-25 JP JP2509375A patent/JPH04503608A/en active Pending
- 1990-06-25 AT AT90112064T patent/ATE114717T1/en not_active IP Right Cessation
- 1990-06-25 DE DE4020211A patent/DE4020211A1/en not_active Withdrawn
- 1990-06-25 DK DK90112064.2T patent/DK0410147T3/en active
-
1991
- 1991-02-25 KR KR1019910700212A patent/KR920701439A/en not_active Application Discontinuation
-
1993
- 1993-03-16 AU AU35245/93A patent/AU657205B2/en not_active Ceased
-
1995
- 1995-02-01 IL IL11250795A patent/IL112507A0/en unknown
- 1995-02-27 GR GR950400402T patent/GR3015192T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO902789D0 (en) | 1990-06-22 |
DE4020211A1 (en) | 1991-01-17 |
EP0410147B1 (en) | 1994-11-30 |
KR920701439A (en) | 1992-08-11 |
NZ234212A (en) | 1993-03-26 |
AU657205B2 (en) | 1995-03-02 |
IL112507A0 (en) | 1995-05-26 |
NO902789L (en) | 1990-12-27 |
DK0410147T3 (en) | 1995-03-13 |
WO1991000348A3 (en) | 2004-04-29 |
GR3015192T3 (en) | 1995-05-31 |
IE902270L (en) | 1990-12-25 |
CA2019661A1 (en) | 1990-12-25 |
EP0410147A1 (en) | 1991-01-30 |
IE950434L (en) | 1990-12-25 |
PT94458A (en) | 1991-02-08 |
DE59007818D1 (en) | 1995-01-12 |
AU3524593A (en) | 1993-05-27 |
IE66395B1 (en) | 1995-12-27 |
JPH04503608A (en) | 1992-07-02 |
IE902270A1 (en) | 1991-01-16 |
IL94841A0 (en) | 1991-04-15 |
EP0602687A1 (en) | 1994-06-22 |
AU5779690A (en) | 1991-01-03 |
ATE114717T1 (en) | 1994-12-15 |
AU644078B2 (en) | 1993-12-02 |
WO1991000348A1 (en) | 1991-01-10 |
ES2064537T3 (en) | 1995-02-01 |
PT94458B (en) | 1997-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60143292D1 (en) | Variants of human coagulation factor VII | |
ATE322547T1 (en) | ADENOVIRAL VECTORS FOR THE TREATMENT OF HEMOPHILIA | |
ATE320495T1 (en) | CALCIUM-FREE SUBTILISIN MUTANTS | |
DE69833784D1 (en) | POLYPEPTIDES WITH AMINOOPEPTIDASE ACTIVITY AND FOR THESE ENCODING NUCLEIC ACIDS | |
ATE399857T1 (en) | COMPUTER-MEDIATED ASSEMBLY OF POLYNUCLEOTIDES ENCODING A TARGETED POLYPEPTIDE | |
ATE135371T1 (en) | PROTEIN ASSOCIATED WITH ACUTE PANCREATITIS, AGENTS FOR DIAGNOSING ACUTE PANCREATITIS | |
DE68914664D1 (en) | PURIFIED UBIQUITIN HYDROLASE, THESE ENCODING DNA SEQUENCES, AND THEIR USE TO OBTAIN POLYPEPTIDES. | |
BR9810701A (en) | Trichoderma reesei protein "swollenin" and DNA coding sequences | |
DE69329195D1 (en) | RECOMBINANT DNA MOLECULES ENCODE THE AMINOPEPTIDASE ENZYME AND THEIR APPLICATION FOR THE PRODUCTION OF VACCINES AGAINST HELMINTH INFECTIONS | |
DK0804558T3 (en) | tripeptidyl aminopeptidase | |
DE3853156D1 (en) | POLYESTER FABRIC FOR THE PRODUCTION OF ELECTROPHORESELS AND ELECTROPHORESEL. | |
TR199802376T1 (en) | Oxalate Decarboxylase Coding Gen from Aspergillus Phoenices. | |
ATE218616T1 (en) | HUMAN CIRCULATIVE CYTOKINE CC-1 | |
FI903144A0 (en) | MODIFIED VP1 / P2A ZONER I SNUVVIRUSSYSTEMET. | |
DE69534470T2 (en) | LGMD GENERATING FOR A CALCIUM-DEPENDENT PROTEASE | |
SE9602822D0 (en) | New receptor | |
ES2060134T3 (en) | METALOPROTEASE TISSUE INHIBITOR (TIMP-2). | |
ATE412751T1 (en) | HUMAN TAK1 AND DNA CODING FOR IT | |
EA200100314A1 (en) | PEPTIDE FRAGLES OF CHOLER EXOTOXIN IN OR ENTEROXINE IN AS AN ADJUVANT VACCINE | |
ATE242883T1 (en) | METHOD FOR DETERMINING BLOOD CLOTTING FACTORS VIII AND IX | |
SE9604439D0 (en) | New receptor | |
ATE432985T1 (en) | POLYPEPTIDES WITH NEUTROPHIL STIMULATING ACTIVITY | |
TH9496EX (en) | The mutant species of substiline | |
RU96124779A (en) | DNA ENCODING BACILUS LICHENIFORMIS PWD-1 KERATINASE | |
ATE279520T1 (en) | VARICELLA ZOSTER VIRUS (VZV) IMMUNOREACTIVE PROTEIN VP26 AND ITS DIAGNOSTIC USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed | ||
MM | Patent lapsed |
Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH |